Patent · US Active

Heterocyclic derivatives and their use in the treatment of neurological disorders

US10301296B2 · kind B2 · utility

1Cited by

14References

12Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Sangamesh Badiger · Bengaluru, IN
Murali Chebrolu · Darsi, IN
Konstanze Hurth · Rixheim, FR
Sebastien Jacquier · Hégenheim, FR
Rainer Martin Lueoend · Therwil, CH
Rainer Machauer · Glückstadt, DE
Heinrich Rueeger · Interlaken, CH
Marina Tintelnot-Blomley · Maulburg, DE
Siem Jacob Veenstra · Basel, CH
Markus Voegtle · Lörrach, DE

Key dates

Filing date	Jun 27, 2018
Grant date	May 28, 2019
Priority date	—
Expiry date	Jun 27, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/05
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to novel heterocyclic compounds of the formula in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.